ENLV
Enlivex Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.21
+1.17%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 0.00x
- PEG TTM
- —
- Price / book
- 0.00x
- Price / sales
- —
- Price / cash flow
- -0.26x
Enterprise value
- Enterprise value
- $15.9M
- EV / sales
- —
- EV / EBITDA
- -0.80x
- EV / EBIT
- -0.77x
- Market cap
- $4.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026